Insilico and Beiersdorf use next-generation AI technology in skin research

Beiersdorf and Insilico Medicine, an artificial intelligence company developing end to end drug discovery pipelines, announced today that they are entering a collaboration to jointly discover novel, safe bioactive ingredients for a specific skin...

Researchers uncover a response key to the survival of Mycoplasma genitalium in urogenital tract

A study led by an IBB-UAB research team has managed to identify the mechanisms by which the sexually transmitted bacterium Mycoplasma genitalium (Mge) can persist in conditions with very limited availability of metals, a...

TwinStrand’s Duplex Sequencing Goes Deep

As companies strive to make their sequencing capabilities longer, more accurate, faster, and cheaper, the detection of low frequency DNA mutations remains one limitation that no one has overcome. The young start-up, TwinStrand Biosciences,...

Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment

The founders of Swiss biotech Therachon have launched a new company called VectivBio, also based in Basel, with €31M funding to develop drugs for rare diseases. The spin-out comes after Therachon was acquired by Pfizer...

NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial

The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund the end of a phase IIb trial of its lead fatty acid drug to treat the liver condition NASH,...

LED lighting in greenhouses helps but standards are needed

Rutgers research reveals information gaps on LED lighting for indoor crops Credit: A.J. Both/Rutgers University-New Brunswick While LED lighting can enhance plant growth in greenhouses, standards are needed...

Biotechnology and medicine startups top the Innovators Under 35 Europe list – MobiHealthNews

Blockchain-powered software that ensures drugs’ traceability, a diagnostic tool to identify microbes in the blood and a device to prevent cardiac arrest in heart disease patients are among the winning European projects of a competition...

Mayo Clinic researchers seek radical new approach to treat cocaine addition

In a radical new approach to treat cocaine addition, researchers at the Mayo Clinic are seeking approval for first-in-human studies of a single-dose gene therapy. To support the safety and efficacy of this approach...

Intranasal Anthrax Vaccine Candidate “Off to the Races”

BlueWillow Biologics CEO Dave Peralta BlueWillow Biologics this month plans to vaccinate its first patients with a next-generation anthrax vaccine candidate. The BW-1010 vaccine—developed in partnership with Porton Biopharma Ltd. (PBL)—is designed to outlast the...

Million Veteran Program study sheds light on genetic basis of anxiety

Largest genetic study of anxiety to date reports findings Credit: Robert Lisak In the largest genetic study on anxiety to date, VA researchers found new evidence on the underlying biological causes of the disorder. The study...